Navigation Links
Enlarged Prostate and Erectile Dysfunction Are Subjects of Free Men's Health Seminar
Date:5/27/2009

TUCSON, Ariz., May 27 /PRNewswire/ -- Dr. Peter Burrows from the Arizona Center-Vasectomy/Urology, a specialist in men's health issues, will be leading a free Men's Health Seminar on Saturday June 6th. The program, to be held at 8:30 AM at El Dorado Hospital, will explain the latest treatment options for two of the most common conditions affecting men today: Benign Prostate Hyperplasia (also known as Enlarged Prostate) and Erectile Dysfunction. A question and answer period will follow the program.

At the June 6th presentation, Dr. Burrows will bring clarity to two topics that together affect well over half of all men above the age of 60 in the United States. Benign Prostate Hyperplasia, or BPH, is a natural, non-cancerous enlargement of the prostate. Symptoms of BPH include frequent urination, weak flow, and interrupted sleep--factors that can significantly impact a man's quality of life.

Many men are commonly offered two treatment options for BPH: prescription medication, or a surgical procedure known as Transurethral Resection of the Prostate, or TURP. Both options can be effective, yet both have potential side effects. Dr. Burrows will explain a new procedure involving a minimally invasive laser surgery, from American Medical Systems, that equals the benefits of TURP with fewer potential complications; it can also be performed on an outpatient basis.

Erectile Dysfunction, or ED, is the inability to maintain an erection firm enough for sexual intercourse. Diabetes, heart disease, prostate surgery and medications for other conditions are among the most common physical causes. The good news is that nearly every case is treatable today. Options range from lifestyle changes to medications, as well as more permanent solutions such as penile implants, from American Medical Systems.

Spouses or partners are invited to accompany attendees. The seminar, which is free and open to the public, will last approximately one hour. Refreshments will be served. Space is limited and reservations are strongly advised.

All surgical treatments have inherent and associated risks. The most common risks associated with GreenLight are hematuria, short term dysuria and urinary track infections.

Implanting a penile prosthesis is likely to damage or destroy any remaining natural ability to have an erection. This product is contraindicated for patient with the following conditions:

  • Active urinary infections or active skin infections in the region of surgery.
  • A known sensitivity to silicone or the antibiotic rifampin or tetracyclines.
  • Lupus erythematosus.
  • Taking warfarin, thionamides, isoniazid and halothane
  • Renal disease.

You should talk with your doctor about benefits and risks before moving forward with any treatment option.

To reserve a space, call 866-432-5274 toll-free. (Men's health seminar will be held at El Dorado Hospital in the ground floor cafeteria. Hospital is located at 1400 North Wilmot Rd. Tucson, AZ 85712).


'/>"/>
SOURCE American Medical Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Free Community Seminar; Reviews Treatment Options for Enlarged Prostate
2. Free Community Seminar to Review Treatment Options for Enlarged Prostate
3. Free Community Seminar to Review Treatment Options for Enlarged Prostate
4. Enlarged prostates: The choice of treatment needs careful consideration
5. Microwave treatments for enlarged prostate cause blood pressure surges
6. Super Prostate Product - More Beta-sitosterol, all-natural Best Prostate(TM) Formula for Enlarged Prostate and BPH - Increases Urine Flow, Reduces Waking and Improves Quality of Life
7. Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
8. Preventing or reducing enlarged heart may decrease risk for diabetes
9. Preventing or reducing enlarged heart decreases risk of heart failure
10. Predicting higher risk for prostate cancer diagnosis
11. Carbohydrate restriction may slow prostate tumor growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: